T cell reactivity against the SmD183-119 C terminal peptide in patients with systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 61, Issue 9, 2002, Pages 779-785

  Riemekasten, Gabriela ^a   Weiss, C ^a   Schneider, S ^a   Thiel, A ^a   Bruns, A ^a   Schumann, F ^a   Blass S ^a   Burmester, G R ^a   Hiepe, F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; PEPTIDE; PEPTIDE SMD1 [83-119]; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DNA SYNTHESIS; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ADULT; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CELL DIVISION; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MIDDLE AGED; RIBONUCLEOPROTEINS, SMALL NUCLEAR; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0036720310     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.9.779     Document Type: Article

References (38)

1. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology
2. Autoantibodies to the Sm antigen: Immunological approach to clinical aspects of systemic lupus erythematosus
3. Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE
4. Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus
5. Human T cell clones reactive against U small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals
6. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm
7. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production
8. Laboratory protocols for the identification of Th cell epitopes on self-antigens in mice with systemic autoimmune diseases
9. Characterization of in vivo mutated clones from patients with systemic lupus erythematosus
10. Assessment of clinical parameters associated with increased frequency of mutated T cells in patients with systemic lupus erythematodes
11. Analysis of human T cell and B cell responses against U small nuclear ribonucleoprotein70-kd, B, and D polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease
12. Screening of SLE sera using purified recombinant Sm-D1 protein from a baculovirus expression system
13. A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus
14. 83-191 peptide
15. The revised criteria for the classification of systemic lupus erythematosus
16. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
17. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
18. Derivation of the SLEDAI: A disease activity index for lupus patients
19. P205 is a major target of autoreactive T cells in rheumatoid arthritis
20. Measurement of candida-specific blastogenesis: Comparison of carboxi-fluoresceinsuccinimidyl ester labelling of T cells, thymidine incorporation, and CD69 expression
21. Determination of lymphocyte devision by flow cytometry
22. A sensitive and class specific solid phase enzyme immunoassay for anti-DNA autoantibodies in supernants of lymphocytes cultures and human hybridomas
23. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW) F1 mouse model of systemic lupus erythematosus
24. Nucleosome: A major immunogen for the pathogenic autoantibody-inducing T cells of lupus
25. Major peptide autoepitopes for nucleosome-specific T cells of human lupus
26. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus
27. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting
28. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity
29. Inflamed kidneys of NZB/W mice are a major site for the homostasis of plasma cells
30. Treatment with a consensus peptide based on amino acid sequences in autoantibodes prevents T cell activation by autoantigens and delay disease onset in murine lupus
31. Chronicity of arthritis induced by homologous type II collagen (C II) in rats is associated with anti-C II B cell activation
32. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus
33. B cell process and present lupus autoantigens that initiate autoimmune T cell responses
34. Antibody conjugates mimic specific B cell presentation of antigen: Relationship between T and B cell specificity
35. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus
36. Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis
37. Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates